Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
Massicotte MH, Brassard M, Claude-Desroches M, Borget I, Bonichon F, Giraudet AL, Do Cao C, Chougnet CN, Leboulleux S, Baudin E, Schlumberger M, de la Fouchardière C. Massicotte MH, et al. Among authors: brassard m. Eur J Endocrinol. 2014 Mar 8;170(4):575-82. doi: 10.1530/EJE-13-0825. Print 2014 Apr. Eur J Endocrinol. 2014. PMID: 24424318
A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience.
Gupta MK, Misariu AM, Saydy N, Nichols AC, Laxague F, Eskander A, Li H, Weisbrod N, Pasternak JD, Golbon B, Jin E, van Uum SHM, Brassard M, Lévesque F, Sadeghi N, Subramaniam T, Mlynarek AM, Morand GB, Fortier PH, Fradet L, Ghaznavi S, Chandarana SP, Prisman E, Ayad T, Christopoulos A, Davies JC, Rajaraman M, Corsten M, Rajaraman K, Maniakas A. Gupta MK, et al. Among authors: brassard m. Thyroid. 2023 Nov;33(11):1374-1377. doi: 10.1089/thy.2023.0088. Epub 2023 Nov 1. Thyroid. 2023. PMID: 37725592 No abstract available.
Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.
Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Toubert ME, Torlontano M, Benhamou E, Schlumberger M; THYRDIAG Working Group. Brassard M, et al. J Clin Endocrinol Metab. 2011 May;96(5):1352-9. doi: 10.1210/jc.2010-2708. Epub 2011 Mar 9. J Clin Endocrinol Metab. 2011. PMID: 21389143
Treatment and follow-up of low-risk patients with thyroid cancer.
Schlumberger M, Borget I, Nascimento C, Brassard M, Leboulleux S. Schlumberger M, et al. Among authors: brassard m. Nat Rev Endocrinol. 2011 Aug 9;7(10):625-8. doi: 10.1038/nrendo.2011.133. Nat Rev Endocrinol. 2011. PMID: 21826103 Review.
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.
Giacchero D, Ramacciotti C, Arnault JP, Brassard M, Baudin E, Maksimovic L, Mateus C, Tomasic G, Wechsler J, Schlumberger M, Robert C. Giacchero D, et al. Among authors: brassard m. Arch Dermatol. 2012 Dec;148(12):1418-20. doi: 10.1001/2013.jamadermatol.192. Arch Dermatol. 2012. PMID: 23247489 Clinical Trial. No abstract available.
A Protocol for a Pan-Canadian Prospective Observational Study on Active Surveillance or Surgery for Very Low Risk Papillary Thyroid Cancer.
Sawka AM, Ghai S, Tomlinson G, Baxter NN, Corsten M, Imran SA, Bissada E, Lebouef R, Audet N, Brassard M, Zhang H, Gupta M, Nichols AC, Morrison D, Johnson-Obeski S, Prisman E, Anderson D, Chandarana SP, Ghaznavi S, Jones J, Gafni A, Matelski JJ, Xu W, Goldstein DP; Canadian Thyroid Cancer Active Surveillance Study Group. Sawka AM, et al. Among authors: brassard m. Front Endocrinol (Lausanne). 2021 Jun 10;12:686996. doi: 10.3389/fendo.2021.686996. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34194396 Free PMC article.
58 results